Human plasma IgG1 repertoires are simple, unique, and dynamic
peer-reviewed · Cell Systems · 2021
| Date | 2021-12-01 |
| Type | peer-reviewed |
| Venue | Cell Systems |
| Publisher | Elsevier BV |
| Contribution | downstream-application |
| DOI | 10.1016/j.cels.2021.08.008 |
| Citations (OpenAlex) | 90 |
| Venue 2-year citedness | 6.21 |
Abstract
Although humans can produce billions of IgG1 variants through recombination and hypermutation, the diversity of IgG1 clones circulating in human blood plasma has largely eluded direct characterization. Here, we combined several mass-spectrometry-based approaches to reveal that the circulating IgG1 repertoire in human plasma is dominated by a limited number of clones in healthy donors and septic patients. We observe that each individual donor exhibits a unique serological IgG1 repertoire, which remains stable over time but can adapt rapidly to changes in physiology. We introduce an integrative protein- and peptide-centric approach to obtain and validate a full sequence of an individual plasma IgG1 clone de novo. This IgG1 clone emerged at the onset of a septic episode and exhibited a high mutation rate (13%) compared with the closest matching germline DNA sequence, highlighting the importance of de novo sequencing at the protein level. A record of this paper’s transparent peer review process is included in the supplemental information.
Methods and tools
- Human plasma IgG1 repertoire profiling: De novo MS workflow (LC-MS coupled with Stitch / native MS) for profiling the circulating human plasma IgG1 antibody repertoire, demonstrating individual-specific dynamics: landmark application of de novo to clinical antibodyomics.
Data deposited
- Code for ‘Human plasma IgG1 repertoires are simple, unique, and dynamic’ (as deposited) · 10.6084/m9.figshare.14794173
Data used
- Bottom-up data - sequencing (as deposited) · 10.6084/m9.figshare.13194005
- Middle-down data - sequencing (as deposited) · 10.6084/m9.figshare.13193996
- Profiling data (as deposited) · 10.6084/m9.figshare.13182743
Cites (4)
- Automated Antibody De Novo Sequencing and Its Utility in Biopharmaceutical Discovery (2017) both
- De Novo MS/MS Sequencing of Native Human Antibodies (2017) both
- Complete De Novo Assembly of Monoclonal Antibody Sequences (2016) both
- DirecTag: Accurate Sequence Tags from Peptide MS/MS through Statistical Scoring (2008) both
Cited by (18)
- Mass Spectrometry-Based De Novo Sequencing of N-Glycosylated Light Chains: Linking Urinary Proteoforms to In Situ Renal Amyloid Deposits (2026) both
- Deep coverage and extended sequence reads obtained with a single archaeal protease expedite de novo protein sequencing by mass spectrometry (2026) both
- Sequencing of Polyclonal Antibodies by Integrating Intact Mass, Middle–Down, and De Novo Bottom–Up Mass Spectrometry (2025) both
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases (2025) both
- Simultaneous polyclonal antibody sequencing and epitope mapping by cryo electron microscopy and mass spectrometry (2025) crossref
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases (2024) crossref
- De novo protein sequencing of antibodies for identification of neutralizing antibodies in human plasma post SARS-CoV-2 vaccination (2024) both
- A Handle on Mass Coincidence Errors in De Novo Sequencing of Antibodies by Bottom-up Proteomics (2024) both
- Improved detection of tryptic immunoglobulin variable region peptides by chromatographic and gas-phase fractionation techniques (2024) both
- Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry–based de novo sequencing (2024) both
- de Novo Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination (2024) crossref
- Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients (2024) both
- Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case Study (2023) both
- Reverse engineering the anti-MUC1 hybridoma antibody 139H2 by mass spectrometry-based de novo sequencing (2023) crossref
- A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies (2022) crossref
- No patient is the same; lessons learned from antibody repertoire profiling in hospitalized severe COVID-19 patients (2022) crossref
- Template-Based Assembly of Proteomic Short Reads For De Novo Antibody Sequencing and Repertoire Profiling (2022) both
- Template-based assembly of proteomic short reads for de novo antibody sequencing and repertoire profiling (2022) crossref